NCT06193733View on ClinicalTrials.gov

Dendritic Cell Vaccination to Prevent Hepatocellular Carcinoma Recurrence After Liver Resection-phase II Clinical Trial

PHASE2Not yet recruitingINTERVENTIONAL

Enrollment

74

Participants

Timeline

Start Date

February 19, 2024

Primary Completion Date

February 29, 2028

Study Completion Date

February 29, 2028

Conditions

Hepatocellular Carcinoma

Interventions

BIOLOGICAL

Autologous Dendritic Cell

Biological: Immunotherapy with dendritic cells

All Listed Sponsors

lead

Chang Gung Memorial Hospital

OTHER